Thanks for the reminder, Jim. I have the DVD of this and show it in my
Child/Human Development drugs. It's always gets students' attention and
merits good discussion.
Here is an article about the stunning weight gains for children who are put
on antipsychotic drugs used "offlabel" for nonpsychotic conditions like
ADHD. (The Frontline show Jim Matiya posted, is about the offlabel use of
these drugs in children.)
Cardiometabolic risk of second-generation antipsychotic medications during
first-time use in children and adolescents.
Correll
CU<javascript:__doLinkPostBack('','ss~~AU%20%22Correll%20CU%22%7C%7Csl~~rl','');>
; Manu
P<javascript:__doLinkPostBack('','ss~~AU%20%22Manu%20P%22%7C%7Csl~~rl','');>
; Olshanskiy
V<javascript:__doLinkPostBack('','ss~~AU%20%22Olshanskiy%20V%22%7C%7Csl~~rl','');>
; Napolitano
B<javascript:__doLinkPostBack('','ss~~AU%20%22Napolitano%20B%22%7C%7Csl~~rl','');>
; Kane
JM<javascript:__doLinkPostBack('','ss~~AU%20%22Kane%20JM%22%7C%7Csl~~rl','');>
; Malhotra
AK<javascript:__doLinkPostBack('','ss~~AU%20%22Malhotra%20AK%22%7C%7Csl~~rl','');>
<javascript:__doLinkPostBack('','ss~~AU%20%22Malhotra%20AK%22%7C%7Csl~~rl','');>JAMA:
The Journal Of The American Medical Association [JAMA] 2009 Oct 28; Vol. 302
(16), pp. 1765-73.
And a New York Times article about these findings:
http://www.nytimes.com/2009/10/28/business/28psych.html?hp
Beth Benoit
Granite State College
Plymouth State University
New Hampshire
---
To make changes to your subscription contact:
Bill Southerly ([email protected])
